These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Dendritic cell function in mice lacking Plexin C1. Walzer T; Galibert L; De Smedt T Int Immunol; 2005 Jul; 17(7):943-50. PubMed ID: 15967782 [TBL] [Abstract][Full Text] [Related]
3. Role of PU.1 in MHC class II expression through transcriptional regulation of class II transactivator pI in dendritic cells. Kitamura N; Yokoyama H; Yashiro T; Nakano N; Nishiyama M; Kanada S; Fukai T; Hara M; Ikeda S; Ogawa H; Okumura K; Nishiyama C J Allergy Clin Immunol; 2012 Mar; 129(3):814-824.e6. PubMed ID: 22112519 [TBL] [Abstract][Full Text] [Related]
4. ComPLEXIN new targets for CIITA. Reith W Nat Immunol; 2003 Sep; 4(9):819-20. PubMed ID: 12942078 [No Abstract] [Full Text] [Related]
5. Plexin-A4 negatively regulates T lymphocyte responses. Yamamoto M; Suzuki K; Okuno T; Ogata T; Takegahara N; Takamatsu H; Mizui M; Taniguchi M; Chédotal A; Suto F; Fujisawa H; Kumanogoh A; Kikutani H Int Immunol; 2008 Mar; 20(3):413-20. PubMed ID: 18209113 [TBL] [Abstract][Full Text] [Related]
6. Down-regulation of MHC class II expression through inhibition of CIITA transcription by lytic transactivator Zta during Epstein-Barr virus reactivation. Li D; Qian L; Chen C; Shi M; Yu M; Hu M; Song L; Shen B; Guo N J Immunol; 2009 Feb; 182(4):1799-809. PubMed ID: 19201831 [TBL] [Abstract][Full Text] [Related]
7. Tumor-mediated down-regulation of MHC class II in DC development is attributable to the epigenetic control of the CIITA type I promoter. Choi YE; Yu HN; Yoon CH; Bae YS Eur J Immunol; 2009 Mar; 39(3):858-68. PubMed ID: 19224634 [TBL] [Abstract][Full Text] [Related]
8. MHC class II expression is differentially regulated in plasmacytoid and conventional dendritic cells. LeibundGut-Landmann S; Waldburger JM; Reis e Sousa C; Acha-Orbea H; Reith W Nat Immunol; 2004 Sep; 5(9):899-908. PubMed ID: 15322541 [TBL] [Abstract][Full Text] [Related]
9. Revisiting the specificity of the MHC class II transactivator CIITA in vivo. Otten LA; Leibundgut-Landmann S; Huarte J; Kos-Braun IC; Lavanchy C; Barras E; Borisch B; Steimle V; Acha-Orbea H; Reith W Eur J Immunol; 2006 Jun; 36(6):1548-58. PubMed ID: 16703565 [TBL] [Abstract][Full Text] [Related]
10. A CIITA-independent pathway that promotes expression of endogenous rather than exogenous peptides in immune-privileged sites. Arancibia-Cárcamo CV; Osawa H; Arnett HA; Háskova Z; George AJ; Ono SJ; Ting JP; Streilein JW Eur J Immunol; 2004 Feb; 34(2):471-80. PubMed ID: 14768052 [TBL] [Abstract][Full Text] [Related]
11. CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory. Mortara L; Castellani P; Meazza R; Tosi G; De Lerma Barbaro A; Procopio FA; Comes A; Zardi L; Ferrini S; Accolla RS Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3435-43. PubMed ID: 16740768 [TBL] [Abstract][Full Text] [Related]
12. Class II transactivator promoter activity is suppressed through regulation by a trophoblast noncoding RNA. Geirsson A; Paliwal I; Lynch RJ; Bothwell AL; Hammond GL Transplantation; 2003 Jul; 76(2):387-94. PubMed ID: 12883198 [TBL] [Abstract][Full Text] [Related]
13. Collagen and major histocompatibility class II expression in mesenchymal cells from CIITA hypomorphic mice. Xu Y; McDonald J; Perloff E; Butticè G; Schreiber BM; Smith BD Mol Immunol; 2007 Mar; 44(7):1709-21. PubMed ID: 16982097 [TBL] [Abstract][Full Text] [Related]
14. [Specific promoter activity of CIITA-pI in dendritic cells]. Zhang Y; Shen Q Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Jan; 20(1):55-7. PubMed ID: 15182622 [TBL] [Abstract][Full Text] [Related]
15. Dendritic cells and differential usage of the MHC class II transactivator promoters in the central nervous system in experimental autoimmune encephalitis. Suter T; Malipiero U; Otten L; Ludewig B; Muelethaler-Mottet A; Mach B; Reith W; Fontana A Eur J Immunol; 2000 Mar; 30(3):794-802. PubMed ID: 10741394 [TBL] [Abstract][Full Text] [Related]
16. Function and regulation of MHC class II molecules in T-lymphocytes: of mice and men. Holling TM; Schooten E; van Den Elsen PJ Hum Immunol; 2004 Apr; 65(4):282-90. PubMed ID: 15120183 [TBL] [Abstract][Full Text] [Related]
17. Transfection of dendritic cells (DCs) with the CIITA gene: increase in immunostimulatory activity of DCs. Märten A; Ziske C; Schöttker B; Weineck S; Renoth S; Buttgereit P; Schakowski F; König S; von Rücker A; Allera A; Schroers R; Sauerbruch T; Wittig B; Schmidt-Wolf IG Cancer Gene Ther; 2001 Mar; 8(3):211-9. PubMed ID: 11332992 [TBL] [Abstract][Full Text] [Related]
18. Class II transactivator-mediated regulation of major histocompatibility complex class II antigen expression is important for hematopoietic progenitor cell suppression by chemokines and iron-binding proteins. Broxmeyer HE; Cooper S; Hangoc G; Chang CH Exp Hematol; 2006 Aug; 34(8):1078-84. PubMed ID: 16863914 [TBL] [Abstract][Full Text] [Related]
19. Mini-review: Specificity and expression of CIITA, the master regulator of MHC class II genes. LeibundGut-Landmann S; Waldburger JM; Krawczyk M; Otten LA; Suter T; Fontana A; Acha-Orbea H; Reith W Eur J Immunol; 2004 Jun; 34(6):1513-25. PubMed ID: 15162420 [TBL] [Abstract][Full Text] [Related]
20. Differential expression of MHC class II molecules in highly metastatic breast cancer cells is mediated by the regulation of the CIITA transcription Implication of CIITA in tumor and metastasis development. Shi B; Vinyals A; Alia P; Broceño C; Chen F; Adrover M; Gelpi C; Price JE; Fabra A Int J Biochem Cell Biol; 2006; 38(4):544-62. PubMed ID: 16343978 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]